ArticleCell death & disease2021

A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.